Argenx SE has discontinued the phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate to severe thyroid eye disease (TED ...
Aviceda Therapeutics has released topline results from its phase 2b study, SIGLEC, evaluating AVD-104 in patients with ...
Recently reported findings indicate that cenegermin-bkbj ophthalmic solution (Oxervate; Dompé) may perform as an effective ...
Effective mentorship is crucial for combating burnout and enhancing teaching efficacy, with strategies like precharting, time blocking, and the Eisenhower Decision Matrix (EDM).
Azura Ophthalmics announced it has received positive feedback from a pre-New Drug Application (NDA) meeting with the US Food ...
New grading scales for ocular adverse events in oncology improve clarity and provide drug-dose-modification recommendations, ...
The authors wrote that early diagnosis, adherence to prolonged management, and constant monitoring can allow the cornea to ...
"Lubricating drops" is proposed as a more accurate term, reflecting their primary function of providing lubrication and ...
In the second part, the discussion turns to emerging DED therapies that target tear function and ocular surface homeostasis.
Alcon increases its acquisition offer for STAAR Surgical, emphasizing a final deal amid shareholder debates and delays in the ...
BCVA is inadequate for detecting visual disturbances in conditions like MacTel, which initially affect the parafoveal region.
The team reviews acoltremon’s mechanism in promoting basal tear production and maintaining ocular surface health. The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback